Form 4: Abeona Therapeutics SVP, General Counsel Brendan O'Malley Reports Stock Transaction
SEC Form 4 Filing
Brendan O'Malley, SVP, General Counsel of Abeona Therapeutics, reports disposition of shares to cover tax obligations upon vesting of restricted stock.
Summary
- On September 28, 2024, Brendan M. O'Malley, SVP, General Counsel of Abeona Therapeutics Inc. (ABEO), reported a transaction involving common stock.
- O'Malley disposed of 6,579 shares of common stock at a price of $5.89.
- This transaction was to satisfy tax withholding obligations upon the vesting of restricted stock.
- Following the transaction, O'Malley beneficially owns 273,289 shares of Abeona Therapeutics Inc.
Sentiment
Score: 5
Explanation: This is a neutral report on a routine stock transaction related to executive compensation.
Industry Context
This is a routine disclosure related to executive compensation and tax obligations, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 09/28/2024 | Date of stock transaction |
| 09/30/2024 | Date of signature on the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.